Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Butler

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Diabetes|August 1, 1996
Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunctionM Couce, L A Kane, T D O'Brien, et al.
Diabetes|June 1, 1990
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humansP C Butler, J Chou, W B Carter, et al.
Metabolism: Clinical and Experimental|July 26, 2000
Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunctionB Nyholm, N Pørksen, C B Juhl, et al.
Veterinary Pathology|September 1, 1996
Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): an animal model of human non-insulin-dependent diabetes mellitusT D O'Brien, J D Wagner, K N Litwak, et al.
Metabolism: Clinical and Experimental|September 1, 1991
The effects of human proinsulin on glucose turnover and intermediary metabolismS N Davis, P C Butler, M Brown, et al.
Metabolism: Clinical and Experimental|July 1, 1994
Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjectsO Schmitz, S B Pedersen, A Mengel, et al.
Diabetes|May 20, 1998
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptideW C Soeller, J Janson, S E Hart, et al.
Diabetes|August 28, 2001
Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipigL L Kjems, B M Kirby, E M Welsh, et al.
The American Journal of Physiology|March 1, 1997
IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion ratesN Pørksen, M A Hussain, T L Bianda, et al.
Diabetologia|February 19, 2011
A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humansC J Huang, A E Butler, A Moran, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Diabetes|August 1, 1996
Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunctionM Couce, L A Kane, T D O'Brien, et al.
Diabetes|June 1, 1990
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humansP C Butler, J Chou, W B Carter, et al.
Metabolism: Clinical and Experimental|July 26, 2000
Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunctionB Nyholm, N Pørksen, C B Juhl, et al.
Veterinary Pathology|September 1, 1996
Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): an animal model of human non-insulin-dependent diabetes mellitusT D O'Brien, J D Wagner, K N Litwak, et al.
Metabolism: Clinical and Experimental|September 1, 1991
The effects of human proinsulin on glucose turnover and intermediary metabolismS N Davis, P C Butler, M Brown, et al.
Metabolism: Clinical and Experimental|July 1, 1994
Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjectsO Schmitz, S B Pedersen, A Mengel, et al.
Diabetes|May 20, 1998
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptideW C Soeller, J Janson, S E Hart, et al.
Diabetes|August 28, 2001
Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipigL L Kjems, B M Kirby, E M Welsh, et al.
The American Journal of Physiology|March 1, 1997
IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion ratesN Pørksen, M A Hussain, T L Bianda, et al.
Diabetologia|February 19, 2011
A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humansC J Huang, A E Butler, A Moran, et al.
Pageof 8